132 related articles for article (PubMed ID: 33314135)
1. Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990-2013): Patterns and impact.
Thorkildsen J; Norum OJ; Myklebust TA; Zaikova O
J Surg Oncol; 2021 Feb; 123(2):510-520. PubMed ID: 33314135
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort.
Thorkildsen J; Taksdal I; Bjerkehagen B; Norum OJ; Myklebust TA; Zaikova O
J Surg Oncol; 2020 Jun; 121(7):1115-1125. PubMed ID: 32141094
[TBL] [Abstract][Full Text] [Related]
3. Survival and prognostic factors in conventional G1 chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
World J Surg Oncol; 2019 Sep; 17(1):155. PubMed ID: 31481076
[TBL] [Abstract][Full Text] [Related]
4. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
5. Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort.
Thorkildsen J; Taksdal I; Bjerkehagen B; Haugland HK; Børge Johannesen T; Viset T; Norum OJ; Bruland Ø; Zaikova O
Acta Oncol; 2019 Mar; 58(3):273-282. PubMed ID: 30632866
[TBL] [Abstract][Full Text] [Related]
6. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E; van Coevorden F; Verhoef C; Wouters MW; Kroon HM; Hogendoorn PC; van Houdt WJ
Ann Surg Oncol; 2016 Mar; 23(3):811-7. PubMed ID: 26498768
[TBL] [Abstract][Full Text] [Related]
8. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity.
Cho WH; Song WS; Jeon DG; Kong CB; Koh JS; Kim JI; Lee SY
Ann Surg Oncol; 2011 Dec; 18(13):3755-61. PubMed ID: 21611858
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors in conventional central chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
BMC Cancer; 2018 Aug; 18(1):849. PubMed ID: 30143018
[TBL] [Abstract][Full Text] [Related]
10. Intralesional curettage of central low-grade chondrosarcoma: A midterm follow-up study.
Chen YC; Wu PK; Chen CF; Chen WM
J Chin Med Assoc; 2017 Mar; 80(3):178-182. PubMed ID: 27889461
[TBL] [Abstract][Full Text] [Related]
11. Chondrosarcoma of the hands and feet.
Kask G; Laitinen MK; Stevenson J; Evans S; Jeys LM; Parry MC
Bone Joint J; 2021 Mar; 103-B(3):562-568. PubMed ID: 33641425
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
13. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of low-grade chondrosarcoma involving the appendicular skeleton: long-term functional and oncological outcomes.
Shemesh SS; Pretell-Mazzini J; Quartin PAJ; Rutenberg TF; Conway SA
Arch Orthop Trauma Surg; 2019 Dec; 139(12):1659-1666. PubMed ID: 31020410
[TBL] [Abstract][Full Text] [Related]
15. Intralesional curettage and cementation for low-grade chondrosarcoma of long bones: retrospective study and literature review.
Mermerkaya MU; Bekmez S; Karaaslan F; Danisman M; Kosemehmetoglu K; Gedikoglu G; Ayvaz M; Tokgozoglu AM
World J Surg Oncol; 2014 Nov; 12():336. PubMed ID: 25382793
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
Andreou D; Gilg MM; Gosheger G; Werner M; Hardes J; Pink D; Leithner A; Tunn PU; Streitbürger A
Ann Surg Oncol; 2016 Jan; 23(1):120-5. PubMed ID: 26350369
[TBL] [Abstract][Full Text] [Related]
17. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
18. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
19. Intralesional vs. extralesional procedures for low-grade central chondrosarcoma: a systematic review of the literature.
Zoccali C; Baldi J; Attala D; Rossi B; Anelli V; Annovazzi A; Ferraresi V
Arch Orthop Trauma Surg; 2018 Jul; 138(7):929-937. PubMed ID: 29633075
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of intralesional curettage and cryosurgery for treatment of low-grade chondrosarcoma.
Meftah M; Schult P; Henshaw RM
J Bone Joint Surg Am; 2013 Aug; 95(15):1358-64. PubMed ID: 23925739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
